Dra. María Isabel Zuluaga - Neuróloga

+ Your specialist at Neuro+

Dr. María Isabel Zuluaga Rodas

Clinical neurologist specializing in multiple sclerosis and demyelinating diseases

“Multiple sclerosis and demyelinating diseases have changed a lot in recent years: today there are more treatment options than ever. My job is to stay up to date with the latest evidence, actively participating in research and clinical trials, to offer each patient the management best suited to their case.”

In short

​ Dr. María Isabel Zuluaga Rodas es neuróloga clínica especialista en multiple sclerosis y enfermedades desmielinizantes, formada en la Universidad CES. She completed a Clinical Training Fellowship in Multiple Sclerosis and Demyelinating Diseases at the Multiple Sclerosis Centre of Catalonia (Vall d'Hebron Hospital), awarded by ECTRIMS, and a Master's in Neuroimmunology from the Autonomous University of Barcelona. She has taught in the Clinical Neurology specialization program at Universidad CES and has authored more than ten international scientific publications on multiple sclerosis and neuromyelitis optica. She sees patients at Neuro+, located in El Poblado, Medellín.

+ What our patients say

Real patients. Real results.

Every story is different. What all our patients share is the same certainty: someone finally listened to me.

Reviews
4.9
(97)

Dr. Zuluaga’s training, experience and credentials

Academic training and experience

2017

Master’s in Neuroimmunology

Autonomous University of Barcelona

Advanced training in the immunological basis of demyelinating diseases and their treatment.

NeuroimmunologyInternational subspecialization
2015 – 2016

Clinical Training Fellowship in Multiple Sclerosis and Demyelinating Diseases

ECTRIMS · Multiple Sclerosis Centre of Catalonia (Cemcat) — Vall d'Hebron Hospital, Barcelona, Spain

Specialized clinical and research training in multiple sclerosis and demyelinating diseases at one of the world’s reference centers in this field.

Multiple sclerosisDemyelinating diseases
2011 – 2014

Specialization in Clinical Neurology

Universidad CES – Instituto Neurológico de Colombia, Medellín

Advanced clinical training in the diagnosis and management of nervous system diseases.

Clinical neurology
  • Neurologist, Demyelinating Diseases Unit, Medicarte S.A. (since 2018)
  • Neurologist, Demyelinating Diseases Unit, Instituto Neurológico de Colombia (2015–2021)
  • Professor in the Clinical Neurology specialization program, Universidad CES (2016–2021)
  • Clinical advisor, Cuenta de Alto Costo (since 2023)
  • Rater in international multiple sclerosis clinical trials: Oratorio-HAND (Roche, phase IV) and Evolution (Merck, phase III)

Publications

+ Connect with Dr. Zuluaga

+ Clinical focus

Dr. Zuluaga’s specialties

Dr. María Isabel Zuluaga combines clinical practice with research, with a particular focus on multiple sclerosis, neuromyelitis optica and other demyelinating and inflammatory diseases of the nervous system.

Multiple sclerosis

Diagnosis, treatment and long-term follow-up, with active participation as a rater in international phase III and IV clinical trials.

Neuromyelitis optica and other demyelinating diseases

Comprehensive care, with her own lines of research published in international scientific journals.

Inflammatory and autoimmune diseases of the nervous system

Diagnosis and comprehensive management of inflammatory and autoimmune conditions affecting the nervous system.

+ In their own words

Our patients share their stories

Patients who have already taken the step share their experience. 

+ Frequently asked questions

Frequently asked questions about Dr. María Isabel Zuluaga

If your question isn’t here, message us on WhatsApp. We reply right away.

Where does Dr. Zuluaga see patients?

Consultations take place at Neuro+, located in El Poblado, Medellín.

She has been a Clinical Neurology specialist since 2014 (Universidad CES), with additional training in multiple sclerosis and demyelinating diseases at the Multiple Sclerosis Centre of Catalonia (Vall d’Hebron Hospital, Spain) and a Master’s in Neuroimmunology (Autonomous University of Barcelona, 2017).

She focuses on multiple sclerosis, neuromyelitis optica and other demyelinating and inflammatory diseases of the nervous system, with active participation in research and international clinical trials.